Previous studies reported that miR-222-5p plays a role in the regulation of ERα expression in breast cancer cells by promoting the transition from ER-positive to ER-negative tumors during the progression of cancer [44] and related to circadian clock outputs [45]. The gene discussed is ESR1; the disease is breast carcinoma.